Upload
rob-hallinan
View
235
Download
1
Embed Size (px)
Citation preview
15th ISRRT World CongressApril 24-28, 2008 Durban
Introduction
ISRRT Congress FeedbackISRRT Congress Feedback
Causes of waiting listsCauses of waiting lists
The New Zealand approach to waiting list The New Zealand approach to waiting list recording and wait list managementrecording and wait list management
Future Reporting ChangesFuture Reporting Changes
The Nigerians
From imaging to therapy
John BuscombeJohn Buscombe
Nuclear Medicine PhysicianNuclear Medicine Physician
Royal Free HospitalRoyal Free Hospital
Neuroendocrine tumours
Family of rare tumoursFamily of rare tumoursAssociated with the neuroectodermal ridge Associated with the neuroectodermal ridge
in the embryoin the embryo Includes the followingIncludes the following
CarcinoidCarcinoidPhaechromocytomaPhaechromocytomaSmall cell lung cancerSmall cell lung cancer
Why radionuclide treatment of NETs
Often present too late for curative surgeryOften present too late for curative surgeryLow turn-over rate makes cells less Low turn-over rate makes cells less
susceptible to chemotherapy and external susceptible to chemotherapy and external DXTDXT
Maybe given in patients who have been Maybe given in patients who have been heavily pre-treatedheavily pre-treated
Few side effectsFew side effects
123I mIBG uptake rates (Bomanji et al)
PhaeochromocytomaPhaeochromocytomaNeuroblastomaNeuroblastomaCarcinoidCarcinoidMedullary thyroid CaMedullary thyroid Ca
95 %95 %95 %95 %60 %60 %10 %10 %
Does CT change or symptom relief help predict survival
RFH, review of 38 patient – completed RFH, review of 38 patient – completed 3x5.5GBq I-131 mIBG therapy3x5.5GBq I-131 mIBG therapy
All with minimum of 12 months follow-upAll with minimum of 12 months follow-upLooked at PFS and OS compared toLooked at PFS and OS compared to
CT changesCT changesSymptom responseSymptom response
Overall survival related to symptom response
Overall survival related to change on CT
Pre Rx 6 m
9 m
131I mIBG Therapy Response
Neuroblastoma in a 4 year old
Radiotherapy Waiting List Management: The New Zealand Experience
Rob Hallinan
Clinical Resource Radiation Therapist
Waikato Hospital
Hamilton
New Zealand
Key Stats
18000 new cancer 18000 new cancer registrations per yearregistrations per year
8000 deaths/year8000 deaths/year
7200 patients treated 7200 patients treated with radiotherapy/yearwith radiotherapy/year
Waiting Lists: The New Zealand Experience
Oncological Sites where delay in Radiotherapy has resulted in increased local recurrence rates
Head and NeckHead and Neck High Grade GliomasHigh Grade Gliomas BreastBreast CervixCervix NSCLCNSCLC Soft Tissue SarcomasSoft Tissue Sarcomas OesophagusOesophagus
Waiting List Causes
DemandDemand
SupplySupply ResourceResource
HumanHuman EquipmentEquipment
ProcessProcess ClinicalClinical
0
50
100
150
200
250
300
January February March April May June July August September October November December
Month
2006 Referrals
Resource Factors
Levels of planning, actors, decisions and waiting list effects
Level of planning Actors Decisions Impact
NationalNational GovernmentGovernment Total level of Total level of healthcare healthcare expenditureexpenditure
Insufficient Insufficient funding increases funding increases wait listswait lists
RegionalRegional Healthcare Healthcare purchaserspurchasers
Volumes of Volumes of contractcontract
Incorrect volumes Incorrect volumes lead to wait listslead to wait lists
HospitalHospital Management and Management and specialtiesspecialties
Resource per Resource per specialtyspecialty
Insufficient Insufficient resources resources increase wait listsincrease wait lists
ProcessProcess DepartmentalDepartmental Efficiency of Efficiency of processprocess
Inefficiencies Inefficiencies increase wait listsincrease wait lists
Vissers, J et al. Health Care Management Science 4, 133-142, 2001
The Multidisciplinary Team
Radiation OncologistsRadiation Oncologists
Medical PhysicistsMedical Physicists
Radiation TherapistsRadiation Therapists
EngineersEngineers
Equipment
Treatment CapacityTreatment Capacity
NetworkingNetworking
Immobilisation Immobilisation
Process Factors
Electronic RecordElectronic Record
Small TeamsSmall Teams
MondaysMondays
Value Time/Real Time Ratio
Value TimeValue Time The time spent The time spent
working on a productworking on a product
Real TimeReal Time The total time of the The total time of the
product in the systemproduct in the system
Urgent Referrals
05
1015202530354045
Mon
day
Tue
sday
Wed
nesd
ay
Thu
rsda
y
Frid
ay
Sat
urda
y
Sun
day
New Starts 2008
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
Clinical Factors
FractionationFractionation
BreastBreast
Bony metastasesBony metastases
Prostate HDRProstate HDR
ComplexityComplexity
Radiotherapy Booking Priorities
Source: NZROAC Report 1999
Pitfalls
Joint reporting of radical Joint reporting of radical
and palliative patientsand palliative patients
Inconsistency of Inconsistency of applicationapplication
Too simplistic?Too simplistic?
Needs revision?Needs revision?
Shifting the goalposts
Referral FSA Start of Treatment
Wait List Reporting Criteria 2002
Referral to FSAReferral to FSA
FSA to Start of RxFSA to Start of Rx
Referral to Start of RxReferral to Start of Rx
Waikato DHB Cancer Centre Summary Waikato DHB Cancer Centre Summary
Priority A (Urgent) Priority B (Curative) Priority C (Palliative and other radical) Priority D (Combined chemotherapy and radiation treatment)Priority A (Urgent) Priority B (Curative) Priority C (Palliative and other radical) Priority D (Combined chemotherapy and radiation treatment)
Assessment Assessment
A. Numbers waiting for first specialist assessment A. Numbers waiting for first specialist assessment Dec-07Dec-07
Priority A Priority A Priority B Priority B Priority C Priority C Priority D Priority D TotalTotal
Assesments completed in current month Assesments completed in current month (number of people)(number of people) 99 3636 5050 55 100100
Average wait from referral to assessment Average wait from referral to assessment (days)(days) 11 88 1313 3737
Number of people waiting for assessment at month end Number of people waiting for assessment at month end (people)(people) 00 2121 109109 6868 198198
TreatmentTreatment
B. Time between the first specialist assessment and the start of radiation B. Time between the first specialist assessment and the start of radiation treatment treatment
Dec-07Dec-07
Priority A Priority A Priority B Priority B Priority C Priority C Priority D Priority D TotalTotal
Treatments started in current month Treatments started in current month (number of people)(number of people) Waited < 4 weeksWaited < 4 weeks 88 1515 6767 1515 105105
Waited 4-8 weeksWaited 4-8 weeks 00 11 11 11 33
Waited 8-12 weeksWaited 8-12 weeks 00 00 00 00 00
Waited >12 weeksWaited >12 weeks 00 00 00 00 00
Average wait from assessment to treatment Average wait from assessment to treatment (weeks)(weeks) 0.020.02 1.41.4 1.61.6 2.52.5
Number of people with completed assessments waiting for treatment at month end Number of people with completed assessments waiting for treatment at month end (people)(people) 00 1414 4646 55 6565
C. Time between receipt of referral and the start of radiation treatment C. Time between receipt of referral and the start of radiation treatment Dec-07Dec-07
Priority A Priority A Priority B Priority B Priority C Priority C Priority D Priority D TotalTotal
Treatments started in current month Treatments started in current month (people) (people) Waited < 4 weeksWaited < 4 weeks 77 1111 1313 22 3333
Waited 4-8 weeksWaited 4-8 weeks 00 22 3434 33 3939
Waited 8-12 weeksWaited 8-12 weeks 00 00 11 22 33
Waited >12 weeksWaited >12 weeks 00 00 11 66 77
Total Total 77 1313 4949 1111 8282
Average wait from referral to treatment Average wait from referral to treatment (weeks)(weeks) 0.340.34 2.952.95 5.135.13 1313 4.244.24
National Summary National Summary
Priority A (Urgent) Priority B (Curative) Priority C (Palliative and other radical) Priority D (Combined chemotherapy and radiation treatment)Priority A (Urgent) Priority B (Curative) Priority C (Palliative and other radical) Priority D (Combined chemotherapy and radiation treatment)
Time between the first specialist assessment and the start of Time between the first specialist assessment and the start of
radiation treatment radiation treatment
Dec-07Dec-07
Priority A Priority A Priority B Priority B Priority Priority CC
Priority Priority DD
TotalTotal
Waited < 4 weeksWaited < 4 weeks 4242 5656 226226 33 327327
Waited 4-8 weeksWaited 4-8 weeks 00 2929 6060 1616 105105
Waited 8-12 weeksWaited 8-12 weeks 00 11 1212 44 1717
Waited >12 weeksWaited >12 weeks 00 11 99 4141 5151
TOTALTOTAL 4242 8787 307307 6464 500500
Ministry of Health Monthly Report
National wait times for patients in priority categories A, B & C
HEALTH TARGET100% of patients treated in less than 8 w eeks
0%
20%
40%
60%
80%
100%
July
2007
Aug 2
007
Sept 2007
Oct 2007
Nov 2
007
Dec 2
007
HEALTH TARGET
% Waited < 4 w eeks % Waited 4-8 w eeks
A matter of perspective
PatientPatient
FunderFunder
ClinicianClinician
Service DeliveryService Delivery
Ministry of HealthMinistry of Health
Controversy
What dates are What dates are significant?significant?
DiagnosisDiagnosis SurgerySurgery ReferralReferral FSAFSA Decision to treatDecision to treat Ready to start treatmentReady to start treatment
What factors should What factors should be discounted?be discounted?
Patient morbiditiesPatient morbidities Factors outside Factors outside
oncology department oncology department controlcontrol
Factors outside Factors outside radiation oncology radiation oncology controlcontrol
Categorisation!
Future Changes
Cancer Control Cancer Control Strategy GoalStrategy Goal
MOH ReportingMOH Reporting
CWG ReportingCWG Reporting
MOH Reporting
New Goal FSA to Start < 6 weeksNew Goal FSA to Start < 6 weeksMultivariate analysisMultivariate analysis
CategoryCategoryEthnicityEthnicityDHBDHB
Separation of palliative and radical patientsSeparation of palliative and radical patientsReasons for patients waiting > 6 weeks Reasons for patients waiting > 6 weeks Chemotherapy FSA-Start of TreatmentChemotherapy FSA-Start of Treatment
Reasons for patients waiting > 6 weeks
Post-operative/chemo complicationsPost-operative/chemo complicationsTreatment of intercurrent co-morbiditiesTreatment of intercurrent co-morbiditiesPatient requestPatient requestAwaiting radiology/pathology resultsAwaiting radiology/pathology resultsDental interventionDental interventionOther outside department controlOther outside department controlDepartment/facility constraintDepartment/facility constraint
CWG Reporting Requirements4 Waiting Times
4.1Average Days Referral to FSA days
4.2Ready to Treat (booking date) to Commencement
of Treatment
4.2.1 Urgent (A) - < 24 Hours % Within Guidelines
4.2.2 Curative (B) - within 2weeks % Within Guidelines
4.2.3 Palliative (C) - within 2 weeks % Within Guidelines
4.2.4 Radical (C) -within 4 weeks % Within Guidelines
4.2.5 Pre Scheduled (D) Days
Categorisation Changes
Initial ReferralInitial Referral 1 Urgent1 Urgent 2 Curative2 Curative 3 Radical3 Radical 4 Protocol 4 Protocol 5 Palliative5 Palliative
RT CategorisationRT Categorisation AA BB CC DD C PallC Pall
Colonel Roger Fray
Oncology Referral Database
Colonel Roger Fray
Data EntryData Entry Initial ReferralInitial ReferralDecision to TreatDecision to TreatStart of TreatmentStart of Treatment
Patient DataPatient DataName, NHI Number, DHB, EthnicityName, NHI Number, DHB, Ethnicity
Colonel Roger Fray
Referral InformationReferral Information ReferrerReferrer Referral DateReferral Date CategorisationCategorisation FSA DateFSA Date
Radiotherapy InformationRadiotherapy Information ModalityModality CategorisationCategorisation Radiation OncologistRadiation Oncologist Ready to Treat DateReady to Treat Date Simulation DateSimulation Date Planning DatePlanning Date Start DateStart Date Delay ReasonsDelay Reasons
Actual Wait Times RTT-Start
0
5
10
15
20
25
30
35
Oct-06
Dec-06
Feb-0
7
Apr-0
7
Jun-
07
Aug-0
7
Oct-07
Dec-07
Feb-0
8
Apr-0
8
Prostate
Breast
B
Total Patients on Wait List vs Daily Linac Treatments
0
20
40
60
80
100
120
140
Oct-0
6
Dec-0
6
Feb-0
7
Apr-0
7
Jun-
07
Aug-0
7
Oct-0
7
Dec-0
7
Feb-
08
Apr-0
8
Patients Waiting for RT
Linac Patients
Take Home Messages
Waiting lists are not just a function of staff Waiting lists are not just a function of staff and equipment shortagesand equipment shortages
A national categorisation system needs to A national categorisation system needs to have internal and external consistency of have internal and external consistency of applicationapplication
An independent database is a valuable An independent database is a valuable tool for analysis and reporting of practice.tool for analysis and reporting of practice.
ReferencesImproving Non-Surgical Cancer Treatment Services in New Zealand,Improving Non-Surgical Cancer Treatment Services in New Zealand,
New Zealand Ministry of Health, July 200New Zealand Ministry of Health, July 200
Towards Decision Support for Waiting Lists: An Operations Towards Decision Support for Waiting Lists: An Operations Management View,Management View,
Vissers, J. et al., Health Care Management Science 4, 133-142, Vissers, J. et al., Health Care Management Science 4, 133-142, 20012001
Management of waiting lists for Radiation Therapy, Management of waiting lists for Radiation Therapy,
The Royal Australian and New Zealand College of Radiologists, The Royal Australian and New Zealand College of Radiologists, Faculty of Radiation Oncology, April 2004Faculty of Radiation Oncology, April 2004
Waiting for Radiotherapy,Waiting for Radiotherapy,
Dodwell, D. & Crellin, A; British Medical Journal, 14 January Dodwell, D. & Crellin, A; British Medical Journal, 14 January 20062006
Killing time: The consequences of delays in radiotherapy,Killing time: The consequences of delays in radiotherapy,
Mackillop, W., Radiotherapy and Oncology 84 (2007) 1-4Mackillop, W., Radiotherapy and Oncology 84 (2007) 1-4